Corbus Pharmaceuticals Holdings, Inc. (CRBP)

CRBP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.98	17.2	13.72	17	25.01	85.43
Short-Term Investments	77	131.86	7.18	42.19	72.64	-
Cash & Short-Term Investments	103.98	149.06	20.91	59.2	97.65	85.43
Cash Growth	-34.75%	613.01%	-64.68%	-39.38%	14.30%	169.09%
Accounts Receivable	-	-	-	-	-	1.62
Other Receivables	-	-	-	-	-	0.96
Receivables	-	-	-	-	-	2.58
Prepaid Expenses	3.3	3.63	2.45	0.79	2.37	3.71
Restricted Cash	0.29	0.29	0.19	0.19	0.19	0.35
Total Current Assets	107.57	152.98	23.55	60.18	100.2	92.07
Property, Plant & Equipment	1.56	2.52	4.04	5.5	7	9.32
Other Long-Term Assets	0.39	0.39	0.69	0.63	0.52	0.9
Total Assets	109.51	155.88	28.27	66.31	107.73	102.29
Accounts Payable	2.74	4.79	3.18	2.17	1.78	7.38
Accrued Expenses	12.58	5.43	11.03	6	10.09	22.01
Current Portion of Long-Term Debt	-	-	16.21	3.15	3.86	0.71
Current Portion of Leases	1.74	1.61	1.44	1.28	1.14	1
Other Current Liabilities	-	-	0.04	0.04	0.13	0.8
Total Current Liabilities	17.06	11.82	31.89	12.64	17.01	31.9
Long-Term Debt	-	-	-	15.98	15.64	18.03
Long-Term Leases	0.31	1.63	3.24	4.68	5.96	7.09
Other Long-Term Liabilities	-	-	0.04	0.02	0.02	-
Total Liabilities	17.37	13.45	35.18	33.32	38.62	57.02
Common Stock	0	0	-	0	0	0.01
Additional Paid-In Capital	627.02	619.29	429.78	425.2	418.9	349.36
Retained Earnings	-534.88	-476.89	-436.68	-392.08	-349.73	-304.09
Comprehensive Income & Other	-0	0.04	-0	-0.13	-0.06	-
Shareholders' Equity	92.15	142.43	-6.91	32.99	69.11	45.27
Total Liabilities & Equity	109.51	155.88	28.27	66.31	107.73	102.29
Total Debt	2.05	3.24	20.89	25.09	26.59	26.84
Net Cash (Debt)	101.93	145.82	0.02	34.11	71.06	58.6
Net Cash Growth	-34.55%	694295.24%	-99.94%	-52.00%	21.26%	162.73%
Net Cash Per Share	8.33	13.36	0.00	8.18	17.35	22.50
Filing Date Shares Outstanding	17.55	12.23	10.49	4.17	4.17	4.17
Total Common Shares Outstanding	12.53	12.18	4.42	4.17	4.17	3.3
Working Capital	90.51	141.16	-8.35	47.54	83.2	60.18
Book Value Per Share	7.35	11.69	-1.56	7.91	16.56	13.74
Tangible Book Value	92.15	142.43	-6.91	32.99	69.11	45.27
Tangible Book Value Per Share	7.35	11.69	-1.56	7.91	16.56	13.74
Machinery	1.13	1.13	1.2	1.38	1.43	2.25
Leasehold Improvements	3.33	3.33	3.33	3.33	3.33	4.16

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q